欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号LT/H/0206/002
药品名称Uractonum 50 mg
活性成分
    • Spironolactone 50.0 mg
剂型Film-coated tablet
上市许可持有人Medochemie Limited 1-10 Constantinoupoleos Limassol 3011 Cyprus
参考成员国 - 产品名称Lithuania (LT)
Spironolactone Medochemie 50 mg plėvele dengtos tabletės
互认成员国 - 产品名称
    • Bulgaria (BG)
      Spironolactone Medochemie 50mg film-coated tablets
    • Cyprus (CY)
      Spironolactone Medochemie 50mg film-coated tablets
    • Malta (MT)
      Spironolactone Medochemie 50mg film-coated tablets
    • Latvia (LV)
    • Estonia (EE)
许可日期2024/09/18
最近更新日期2024/09/18
药物ATC编码
    • C03DA01 spironolactone
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase